Skip to main content
SpringerLink
Log in

Significance of micrometastases in colorectal cancer

  • Educational Review
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Conclusion

The combined effort of pathologists, molecular biologists, and surgeons has allowed a very focused examination on select lymph nodes within a specimen. As such, clinicians are afforded the pathologic diagnosis with a smaller and smaller extent of disease. At present, the detection threshold has exceeded the clinical knowledge: that is to say, the mere presence of disease in minute amounts has not yet been studied extensively enough to identify prognostic information from such or to alter the current therapy offered to patients. Continued efforts to define “clinically relevant micrometastases” should persist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000.CA Cancer J Clin 2000;50:7–33.

    PubMed  CAS  Google Scholar 

  2. Cohen AM, Minsky BD, Schilsky RL. Cancer of the colon. In: DeVita VT, Hellman S, Rosenbert SA, eds.Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott. 1997:1144–97.

    Google Scholar 

  3. Black RB, Roberts MM, Stewart HJ, et al. The search for occult metastases in breast cancer: does it add to established staging methods.Aust N Z J Surg 1980;50:574–9.

    PubMed  CAS  Google Scholar 

  4. Huvos AG, Hutter RV, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer.Ann Surg 1971;173:44–6.

    Article  PubMed  CAS  Google Scholar 

  5. Gray RJ, Cox CE, Reintgen DS. Importance of missed axillary micrometastases in breast cancer patients.Breast J 2001;7:303–7.

    Article  PubMed  CAS  Google Scholar 

  6. Fisher ER, Palekar A, Rockette H, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases.Cancer 1978;42:2032–8.

    Article  PubMed  CAS  Google Scholar 

  7. Izbicki JR, Hosch SB. Minimal dissemination of solid epithelial tumours: impact on staging and therapeutic strategy.Br J Surg 1997;84:897–8.

    Article  PubMed  CAS  Google Scholar 

  8. Fielding LP, Phillips RK, Fry JS, Hittinger R. Prediction of ourcome after curative resection for large bowel cancer.Lancet 1986; 2:904–7.

    Article  PubMed  CAS  Google Scholar 

  9. Wiggers T, Arends JW, Schutte B, Volovics L, Bosman FT. A multivariate analysis of pathologic prognostic indicators in large bowel cancer.Cancer 1988;61:386–95.

    Article  PubMed  CAS  Google Scholar 

  10. Cohen AM, Tremiterra S, Candela F, Thaler HT, Sigurdson ER. Prognosis of node-positive colon cancer.Cancer 1991;67:1859–61.

    Article  PubMed  CAS  Google Scholar 

  11. Hyder JW, Talbott TM, Maycroft TC. A critical review of chemical lymph node clearance and staging of colon and rectal cancer at Ferguson Hospital, 1977 to 1982.Dis Colon Rectum 1990;33: 923–5.

    Article  PubMed  CAS  Google Scholar 

  12. Wolmark N, Fischer B, Wieand HS. The prognostic value of the modifications of the Dukes’ C class of colorectal cancer. An analysis of the NSABP clinical trials.Ann Surg 1986;203:115–22.

    Article  PubMed  CAS  Google Scholar 

  13. Ichikawa Y, Ishikawa T, Momiyama N, et al. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.Clin Exp Metastasis 1998; 16:3–8.

    Article  PubMed  CAS  Google Scholar 

  14. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered.Am J Clin Pathol 1996;106:209–16.

    PubMed  CAS  Google Scholar 

  15. Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance.Br J Surg 1989;76:1165–7.

    Article  PubMed  CAS  Google Scholar 

  16. Cawthorn SJ, Gibbs NM, Marks CG. Clearance technique for the detection of lymph nodes in colorectal cancer.Br J Surg 1986;73: 58–60.

    Article  PubMed  CAS  Google Scholar 

  17. Ratto C, Sofo L, Ippoliti M, et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance.Dis Colon Rectum 1999;42:143–54; discussion 154–8.

    Article  PubMed  CAS  Google Scholar 

  18. Hernanz F, Revuelta S, Redondo C, Madrazo C, Castaillo J, Gomez-Fleitas M. Colorectal adenocarcinoma: quality of the assessement of lymph node metastases.Dis Colon Rectum 1994;37:373–6; discussion 376–7.

    Article  PubMed  CAS  Google Scholar 

  19. Goldstein NS. Recent pathology related advances in colorectal adenocarcinomas.Eur J Surg Oncol 2001;27:446–50.

    Article  PubMed  CAS  Google Scholar 

  20. Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The National Cancer Data Base. Report on colon cancer.Cancer 1996;78:918–26.

    Article  PubMed  CAS  Google Scholar 

  21. Wong SH, Severino R, Honnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma.J Clin Oncol. 1999;17:2896–900.

    PubMed  CAS  Google Scholar 

  22. Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K. The extent of lymph node dissection for colon carcinoma: the potential impact on laparoscopic surgery.Cancer 1997;80:188–92.

    Article  PubMed  CAS  Google Scholar 

  23. Franklin ME Jr, Rosenthal D, Abrego-Medina D, et al. Prospective comparison of open vs. laparoscopic colon surgery for carcinoma. Five-year results.Dis Colon Rectum 1996;39(Suppl 10):S35–46.

    Article  Google Scholar 

  24. Haboubi NY, Abdalla SA, Amini S, et al. The novel combination of fat clearance and immunohistochemistry improves prediction of the outcome of patients with colorectal carcinomas: a preliminary study.Int J Colorectal Dis 1998;13:99–102.

    Article  PubMed  CAS  Google Scholar 

  25. Rodriguez-Bigas MA, Maamoun S, Weber TK, Penetrante RB, Blumenson LE, Petrelli NJ. Clinical significance of colorectal cancer: metastases in lymph nodes < 5 mm in size.Ann Surg Oncol 1996;3:124–30.

    Article  PubMed  CAS  Google Scholar 

  26. Haboubi NY, Clark P, Kaftan SM, Schofield PF. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma.J R Soc Med 1992;85: 386–8.

    PubMed  CAS  Google Scholar 

  27. Mainprize KS, Kulacoglu H, Hewavisinthe J, Savage A, Mortensen N, Warren BF. How many lymph nodes to stage colorectal carcinoma?J Clin Pathol 1998;51:165–6.

    Article  PubMed  CAS  Google Scholar 

  28. Koren R, Siegal A, Klein B, et al. Lymph node-revealing solution: simple new method for detecting minute lymph nodes in colon carcinoma.Dis Colon Rectum 1997;40:407–10.

    Article  PubMed  CAS  Google Scholar 

  29. Tschmelitsch J, Klimstra DS, Cohen AM. Lymph node micrometastases do not predict relapse in stage II colon cancer.Ann Surg Oncol 2000;7:601–8.

    PubMed  CAS  Google Scholar 

  30. Jannink I, Fan M, Nagy S, Rayudu G, Dowlatshahi K. Serial sectioning of sentinel nodes in patients with breast caner: a pilot study.Ann Surg Oncol 1998;5:310–4.

    Article  PubMed  CAS  Google Scholar 

  31. van Wyk Q, Hosie KB, Balsitis M. Histopathological detection of lymph node metastases from colorectal carcinoma.J Clin Pathol 2000;53:685–7.

    Article  PubMed  Google Scholar 

  32. O’Brien MJ, Zamcheck N, Burke B, Kirkham SE, Saravis CA, Gottlieb LS. Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues. Assessment of diagnostic value.Am J Clin Pathol 1981;75:283–90.

    PubMed  CAS  Google Scholar 

  33. Davidson BR, Sams VR, Styles J, Deane C, Boulos PB. Detection of occult nodal metastases in patients with colorectal carcinoma.Cancer 1990;65:967–70.

    Article  PubMed  CAS  Google Scholar 

  34. Cutait R, Alves VA, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins.Dis Colon Rectum 1991;34:917–20.

    Article  PubMed  CAS  Google Scholar 

  35. Greenson JK, Jsenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.Cancer 1994;73:563–9.

    Article  PubMed  CAS  Google Scholar 

  36. Jeffers MD, O’Dowd GM, Mulcahy H, Stagg M, O’Donoghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma.J Pathol 1994;172:183–7.

    Article  PubMed  CAS  Google Scholar 

  37. Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes’ B colocrectal carcinoma: an immunohistochemical study.Eur J Surg 1996;162:637–42.

    PubMed  CAS  Google Scholar 

  38. Broll R, Schauer V, Schimmelpenning H, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study.Dis Colon Rectum 1997;40: 1465–71.

    Article  PubMed  CAS  Google Scholar 

  39. Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer?Dis Colon Rectum 1998;41:1244–9.

    Article  PubMed  CAS  Google Scholar 

  40. Clarke G, Ryan E, Crowe J, O’Keane JC, MacMathuna P. Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer.Eur J Histochem 1999;43:311–6.

    PubMed  CAS  Google Scholar 

  41. Isaka N, Nozue M, Doy M, Fukao K. Prognostic significance of perirectal lymph node micrometastases in Dukes’ B rectal carcinoma: an immunohistochemical study by CAM5.2.Clin Cancer Res 1999;5:2065–8.

    PubMed  CAS  Google Scholar 

  42. Nakanishi Y, Ochiai A, Yamauchi Y, Moriya Y, Yoshimura K, Hirohashi S. Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study.Oncology 1999;7:276–80.

    Article  Google Scholar 

  43. Andreola S, Leo E, Belli F, Gallino G, Sirizzotti G, Sampietro G. Adenocarcinoma of the lower third of the rectum: metastases in lymph nodes smaller than 5 mm and occult micrometastases—preliminary results on early tumor recurrence.Ann Surg Oncol 2001;8:413–7.

    Article  PubMed  CAS  Google Scholar 

  44. Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.J Clin Oncol 2001;19:1128–36.

    PubMed  CAS  Google Scholar 

  45. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer.Ann Surg Oncol 2001;8:300–4.

    Article  PubMed  CAS  Google Scholar 

  46. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.J Clin Oncol 1994;12:725–9.

    PubMed  CAS  Google Scholar 

  47. Tsavellas G, Patel H, Allen-Mersh TG. Detection and clinical significance of occult tumour cells in colorectal cancer.Br J Surg 2001;88:1307–20.

    Article  PubMed  CAS  Google Scholar 

  48. Hardingham JE, Kotasek D, Farmer B, et al. Immunobead-PCR: a technique for the detection of circulating tumour cells using immunomagnetic beads and the polymerase chain reaction.Cancer Res 1993;53:3455–8.

    PubMed  CAS  Google Scholar 

  49. Bernini A, Spencer M, Frizelle S, et al. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.Cancer Detect Prev 2000;24:72–9.

    PubMed  CAS  Google Scholar 

  50. Hayashi N, Arakawa H, Nagase H, et al. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method.Cancer Res 1994;54:3853–6.

    PubMed  CAS  Google Scholar 

  51. Hayashi N, Ito I, Yanagisawa A, et al. Genetic diagnosis of lymphnode metastasis in colorectal cancer.Lancet 1995;345:1257–9.

    Article  PubMed  CAS  Google Scholar 

  52. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer.N Engl J Med 1998;339:223–8.

    Article  PubMed  CAS  Google Scholar 

  53. Miyake Y, Yamamoto H, Fujiwara Y, et al. Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: a study of lymphatic mapping.Clin Cancer Res 2001;7:1350–7.

    PubMed  CAS  Google Scholar 

  54. Mori M, Mimori K, Inoue H, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.Cancer Res 1995;55:3417–20.

    PubMed  CAS  Google Scholar 

  55. Sanchez-Cespedes M, Esteller M, Hibi K, et al. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.Clin Cancer Res 1999;5:2450–4.

    PubMed  CAS  Google Scholar 

  56. Funke I, Schraut W. Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated.J Clin Oncol 1998;16:557–66.

    PubMed  CAS  Google Scholar 

  57. Schlimok G, Funke I, Bock B, Schweiberer B, Witte J, Riethmuller G. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance.J Clin Oncol 1990;8:831–7.

    PubMed  CAS  Google Scholar 

  58. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmuller G. Prognostic sigfinicance of micrometastatic tumour cells in bone marrow of colorectal cancer patients.Lancet 1992;340:685–9.

    Article  PubMed  CAS  Google Scholar 

  59. Juhl H, Stritzel M, Wroblewski A, et al. Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients.Int J Cancer 1994;57: 330–5.

    Article  PubMed  CAS  Google Scholar 

  60. O’Sullivan GC, Collins JK, Kelly J, Morgan J, Madden M, Shanahan F. Micrometastases: marker of metastatic potential or evidence of residual disease?Gut 1997;40:512–5.

    PubMed  CAS  Google Scholar 

  61. Soeth E, Vogel I, Roder C, et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR.Cancer Res 1997;57:3106–10.

    PubMed  CAS  Google Scholar 

  62. Weitz J, Koch M, Kienle P, et al. Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer.Ann Surg 2000;232:66–72.

    Article  PubMed  CAS  Google Scholar 

  63. Flatmark K, Bjornland K, Johannessen HO, et al. Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients.Clin Cancer Res 2002;8:444–9.

    PubMed  Google Scholar 

  64. Ghossein RA, Coit D, Brennan M, et al. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma.Clin Cancer Res 1998;4:419–28.

    PubMed  CAS  Google Scholar 

  65. Olsson CA, de Vries GM, Raffo AJ, et al. Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.J Urol 1996;155:1557–62.

    Article  PubMed  CAS  Google Scholar 

  66. Molnar B, Ladanyi A, Tanko L, Sreter L, Tulassay Z. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients.Clin Cancer Res 2001;7:4080–5.

    PubMed  CAS  Google Scholar 

  67. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy.Cancer Res 1977;37:646–50.

    PubMed  CAS  Google Scholar 

  68. Patel H, Le Marer N, Wharton RQ, et al. Clearance of circulating tumor cells after excision of primary colorectal cancer.Ann Surg 2002;235:226–31.

    Article  PubMed  Google Scholar 

  69. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.Cancer Res 1990;50:6130–8.

    PubMed  CAS  Google Scholar 

  70. Denis MG, Lipart C, Leborgne J, et al. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients.Int J Cancer 1997;74:540–4.

    Article  PubMed  CAS  Google Scholar 

  71. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.Cancer Res 1974;34:997–1004.

    PubMed  CAS  Google Scholar 

  72. Mori M, Mimori K, Ueo H, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease.Int J Cancer 1996;68:739–43.

    Article  PubMed  CAS  Google Scholar 

  73. Weitz J, Kienle P, Lacroix J, et al. Dissemination of tumor cells in pateints undergoing surgery for colorectal cancer.Clin Cancer Res 1998;4:343–8.

    PubMed  CAS  Google Scholar 

  74. Funaki NO, Tanaka J, Sugiyama T, et al. Perioperative quantitative analysis of cytokeratin 20 mRNA in peripheral venous blood of patients with colorectal adenocarcinoma.Oncol Rep 2000;7:271–6.

    PubMed  CAS  Google Scholar 

  75. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection.Ann Surg 2000;232:58–65.

    Article  PubMed  CAS  Google Scholar 

  76. Sadahiro S, Suzuki T, Tokunaga N, et al. Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase-polymerase chain reaction.Cancer 2001;92:1251–8.

    Article  PubMed  CAS  Google Scholar 

  77. Taniguchi T, Makino M, Suzuki K, Kaibara N. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma.Cancer 2000;89:970–6.

    Article  PubMed  CAS  Google Scholar 

  78. Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a “sentinel node” in cancer of the parotid.Cancer 1960;13:77–8.

    Article  PubMed  CAS  Google Scholar 

  79. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 1992;127:392–9.

    PubMed  CAS  Google Scholar 

  80. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 1994;220:391–8; discussion 398–401.

    Article  PubMed  CAS  Google Scholar 

  81. Gabriel WB, Dukes C, Bussey HJR. Lymphatic spread in cancer of the rectum.Br J Surg 1935;23:395–413.

    Article  Google Scholar 

  82. Merrie AE, Phillips LV, Yun K, McCall JL. Skip metastases in colon cancer: assessment by lymph node mapping using molecular detection.Surgery 2001;129:684–91.

    Article  PubMed  CAS  Google Scholar 

  83. Saha S, Nora D, Wong JH, Weise D. Sentinel lymph node mapping in colorectal cancer—a review.Surg Clin North Am 2000;80: 1811–9.

    Article  PubMed  CAS  Google Scholar 

  84. Bilchik AJ, Saha S, Tsioulias GJ, Wood TF, Morton DL. Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms.Ann Surg Oncol 2001;8(Suppl 9):82S-85S.

    PubMed  CAS  Google Scholar 

  85. Wood TF, Saha S, Morton DL, et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques.Ann Surg Oncol 2001;8:150–7.

    Article  PubMed  CAS  Google Scholar 

  86. Wong JH, Steineman S, Calderia C, Bowles J, Namiki T. Ex vivo sentinel node mapping in carcinoma of the colon and rectum.Ann Surg 2001;233:515–21.

    Article  PubMed  CAS  Google Scholar 

  87. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma.Br J Surg 1999;86:482–6.

    Article  PubMed  CAS  Google Scholar 

  88. Saha S, Wiese D, Badin J, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging.Ann Surg Oncol 2000;7:120–4.

    Article  PubMed  CAS  Google Scholar 

  89. Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun K, McCall JL. Diagnostic use of the sentinel node in colon cancer.Dis Colon Rectum 2001;44:410–7.

    Article  PubMed  CAS  Google Scholar 

  90. Bendavid Y, Latulippe JF, Younan RJ, et al. Phase I study on sentinel lymph node mapping in colon cancer: a preliminary report.J Surg Oncol 2002;79:81–4; discussion 85.

    Article  PubMed  Google Scholar 

  91. Patten LC, Berger DH, Cleary KR, et al. A prospective evaluation of radiocolloid and immunohistochemical staining in colon cancer lymphatic mapping.Ann Surg Oncol 2002;9:S72.

    Google Scholar 

  92. Ko AS, Broderick-Villa GA, O’Connell TX, DiFronzo LA. Does tumor burden limit the success and accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer?Ann Surg Oncol 2002;9:S71-S72.

    Article  Google Scholar 

  93. Wood TF, Spirt M, Rangel D, et al. Lymphatic mapping improves staging during laparoscopic colectomy for cancer.Surg Endosc 2001;15:715–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Florida College of Medicine, 1600 S.W. Archer Rd., Room 6184, P.O. Box 100286, 32610, Gainesville, FL

    Robert J. Feezor MD, Edward M. Copeland III MD & Steven N. Hochwald MD

Authors
  1. Robert J. Feezor MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edward M. Copeland III MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven N. Hochwald MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven N. Hochwald MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feezor, R.J., Copeland, E.M. & Hochwald, S.N. Significance of micrometastases in colorectal cancer. Annals of Surgical Oncology 9, 944–953 (2002). https://doi.org/10.1007/BF02574511

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02574511

Key Words

Search

Navigation